Fig. 3: Flubendazole affacts tumorigenesis of SF-268 cells in vivo.
From: Flubendazole inhibits glioma proliferation by G2/M cell cycle arrest and pro-apoptosis
a Image of tumors dissected from 12 nude mice (n = 6 for each group). SF-268 cells were incubated into the right armpit regions of each mouse. After injection 10 days, mice were randomly distributed into two groups, flubendazole-treated group (25 mg/kg per day) and control group. b The tumors weight were weighed and presented by scatter plot. c Tumor volumes were measured on the indicated days and drew into the tumor growth curves. d The body weight of each mouse was monitored during the experiment. e Representative immunohistochemistry staining images of Ki-67 from tumor tissues in each group. f Mean positive rates ± SD were shown (n = 6). The data represent the mean ± SD of three independent experiments.*P < 0.05 (vs. control)
